임상 연구자: 사전 경쟁 연구에서 모델링 및 시뮬레이션을 사용하여 신약 개발의 현대화 촉진

It’s hard to imagine that 37 leading, global biopharmaceutical companies would be willing to partner to develop a new technology and progress a scientific field, but that is exactly what the members of the Simcyp Consortium have achieved. Working together in a pre-competitive, collaborative research environment, the consortium’s members are advancing physiologically based pharmacokinetic (PBPK) mechanistic modeling and simulation to predict pharmacokinetic/pharmacodynamic (PK/PD) outcomes in virtual patient populations…